Recall of INSULIN SYRINGE WITH NEEDLE

According to Health Canada (via FOI), this recall involved a device in Canada that was produced by BECTON DICKINSON CANADA INC..

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Event ID
    19057
  • Event Risk Class
    III
  • Event Initiated Date
    2011-06-27
  • Event Country
  • Event Source
    HC
  • Notes / Alerts
    Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
  • Extra notes in the data
  • Reason
    Bd has determined that a quantity of product packaged within experimental shelf cartons made of recycled cardboard was released to consumers within lot 0039920. each of the experimental shelf cartons is labeled with an orange "change control" sticker identifying it as the experimental material. note: only the outer packaging shelf carton material was "experimental". the actual syringe products and inner sterility barrier packaging were all the correct qualified materials .

Device

  • Model / Serial
    Model Catalog: 329424 (Lot serial: 0039920)
  • Product Description
    bd 1ml 28G INSULIN SYRINGE WITH NEEDLE
  • Manufacturer

Manufacturer